Header cover image

Polish Biotech Stocks

Results

7

0 new

Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.

7 companies

Celon Pharma

Market Cap: zł1.1b

An integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations.

CLN

zł21.05

7D

2.7%

1Y

-8.9%

Selvita

Market Cap: zł552.5m

Provides drug discovery, drug development, and contract testing services in Poland.

SLV

zł30.10

7D

1.0%

1Y

8.7%

Ryvu Therapeutics

Market Cap: zł356.1m

A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.

RVU

zł15.40

7D

7.8%

1Y

-48.3%

Biogened

Market Cap: zł45.7m

Produces and sells cosmetics and toiletries in Poland.

BGD

zł18.60

7D

2.8%

1Y

-27.9%

Genomed Spólka Akcyjna

Market Cap: zł34.4m

Provides DNA sequencing and analysis and diagnostics services for congenital diseases in Poland.

GEN

zł26.00

7D

2.4%

1Y

0%

Stem Cells Spin

Market Cap: zł17.4m

Operates as a biotechnology company in Poland.

SCS

zł0.42

7D

8.2%

1Y

75.0%

Labocanna

Market Cap: zł4.2m

Engages in the cultivation, production, and distribution of hemp product.

LCN

zł0.20

7D

-5.3%

1Y

-34.0%